peptide complex Zhenoluten actively influences the regulation of female fertility by means of directed and selective influence ovarian peptides isolated from young calves organ tissues (up to 11 months).
The peptides are an important component of nutrition ovarian cells as well as affect the process of protein synthesis and gene expression.
Peptides are produced by the ovaries at an early age, but as they grow older and larger loads on the human body protein synthesis activity decreases, as a result of failure of peptides disrupted functional ovarian cells.
Today resist deficiency ovarian peptides may be due to the drug Zhenoluten based on peptides ovarian tissue of mammals, thereby making up a pool of regulatory peptides that are produced by the ovaries.
Basic steps Zhenolutena
– optimization of ovarian function;
– reduction of ovarian atrophy;
– reducing the risk of abnormalities in the ovaries
Zhenoluten drug recommended for:
violation of the ovaries work;
failure of the menstrual cycle;
diseases of the reproductive system, hormone-dependent;
The drug proved to be a great Zhenoluten regard to optimizing the functioning of the reproductive system of older women, the side effects were detected. For the treatment of age-related diseases of the ovaries Zhenolutena recommended to use in combination with other medications.
The average rate of reception Zhenoluten preparation is 1-2 months, followed by a 1-3 months to make a break and repeat the treatment.
One Zhenolutena capsule includes 3.6% of ovarian extract and excipients
The composition of the product
Microcrystalline cellulose (E460); sugar beet; lactose; starch; peptide complex A-15 (ovarian peptides); Tween-80.
The daily dose contains: (2 capsules) 20 mg peptide complex A-15
Adults take 1-2 capsules 1-2 times a day during meal time. Duration – 1 month
Composition: 20 capsules of 0.2 g
Amino Acid Blends